U.S. Generic Drugs Market
United States Generic Drugs Market Research Report 2023-2028 - Rise In the Number of Generic Drug Approvals
December 12, 2023 11:23 ET | Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market 2018-2028: Key Players Include Teva, Sandoz, Viatris, Sun Pharma, and Others
August 07, 2023 09:03 ET | Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Generic Drugs Market- Global Industry Size, Share, Trends, Opportunity and Forecast, 2018-2028F By Type (Small Molecule Generics vs Biosimilars), By...
U.S. Generic Drugs Market
United States Generic Drugs Market Forecast Report 2023: A $147.57 Billion Market by 2028 from $101 Billion in 2022 - Increasing Prevalence of Life-threatening Diseases Creating Opportunities
May 10, 2023 10:18 ET | Research and Markets
Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added...
Global Branded Generics Market
Outlook on the Branded Generics Global Market to 2028 - Featuring Par Pharmaceuticals, Sandoz International, Aspen Holdings and Hetero Among Others
September 23, 2022 04:53 ET | Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Therapeutic Application, Distribution Channel, Drug Class, and...
United States Generic Drugs Market
United States Generic Drugs Market Report 2021: Small Molecule Generics v/s Biosimilars - Forecast to 2026
February 07, 2022 05:23 ET | Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Application, By Mode of Drug Delivery, By Form, By Source, By...
22157.jpg
Global Generic Drugs (Small Molecule Generics vs Biosimilars) Markets Report 2021: Market was Valued at $371.04 Billion in 2020 and is Anticipated to Reach $564.43 Billion in 2026
April 19, 2021 06:13 ET | Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Others),...